Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

GBD 2015 Mortality and Causes of Death Collaborators

doi:10.1016/S0140-6736(16)31012-1

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

GBD 2015 Mortality and Causes of Death Collaborators

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1459-1544
Number of pages	86
Journal	The Lancet
Volume	388
Issue number	10053
DOIs	https://doi.org/10.1016/S0140-6736(16)31012-1
Publication status	Published - 8 Oct 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(16)31012-1

Cite this

@article{7c35552a82f04220836bc281ba5866c6,

title = "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015",

author = "\{GBD 2015 Mortality and Causes of Death Collaborators\} and H. Wang and M. Naghavi and C. Allen and Barber, \{R. M.\} and A. Carter and Casey, \{D. C.\} and Charlson, \{F. J.\} and Chen, \{A. Z.\} and Coates, \{M. M.\} and M. Coggeshall and L. Dandona and Dicker, \{D. J.\} and Erskine, \{H. E.\} and Ferrari, \{A. J.\} and C. Fitzmaurice and K. Foreman and Forouzanfar, \{M. H.\} and Johnson, \{C. O.\} and Lim, \{S. S.\} and Thomas, \{B. A.\} and B. Bell and A. Brown and J. Brown and C. Cooper and S. Liu and L. Wang and S. Yu and P. James and K. Alam and Taylor, \{H. R.\} and A. Agarwal and Kemp, \{A. H.\} and J. Leigh and A. Basu and Lucas, \{R. M.\} and W. Chen and M. Rahman and A. Singh and Khan, \{A. R.\} and C. Huang and H. Huang and H. Zhang and M. Levi and Y. Li and Y. Liu and Phillips, \{M. R.\} and M. Rahman and S. Saha and G. Shaddick and White, \{R. A.\}",

note = "Funding Information: We thank the countless individuals who have contributed to the Global Burden of Disease Study 2015 in various capacities. The data reported here have been supplied by the United States Renal Data System (USRDS). Data for this research was provided by MEASURE Evaluation, funded by the United States Agency for International Development (USAID). Collection of these data was made possible by USAID under the terms of cooperative agreement GPO-A-00-08-000\_D3-00. Views expressed do not necessarily reflect those of USAID, the US Government, or MEASURE Evaluation. Parts of this material are based on data and information provided by the Canadian institute for Health Information. However, the analyses, conclusions, opinions and statements expressed herein are those of the author and not those of the Canadian Institute for Health information. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with licence number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law–2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. The following individuals acknowledge various forms of institutional support. Simon I Hay is funded by a Senior Research Fellowship from the Wellcome Trust (\#095066), and grants from the Bill \& Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023 and OPP1132415). Panniyammakal Jeemon is supported by a Clinical and Public Health Intermediate Fellowship from the Wellcome Trust-DBT India Alliance (2015–20). Luciano A Sposato is partly supported by the Edward and Alma Saraydar Neurosciences Fund, London Health Sciences Foundation, London, ON, Canada. George A Mensah notes that the views expressed in this Article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the United States Department of Health and Human Services. Boris Bikbov acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group supported by the International Society of Nephrology (ISN). Ana Maria Nogales Vasconcelos acknowledges that her team in Brazil received funding from Ministry of Health (process number 25000192049/2014-14). Rodrigo Sarmiento-Suarez receives institutional support from Universidad de Ciencias Aplicadas y Ambientales, UDCA, Bogot{\'a}, Colombia. Ulrich O Mueller and Andrea Werdecker gratefully acknowledge funding by the German National Cohort BMBF (grant number OIER 1301/22). Peter James was supported by the National Cancer Institute of the National Institutes of Health (Award K99CA201542). Brett M Kissela would like to acknowledge NIH/NINDS R-01 30678. Louisa Degenhardt is supported by an Australian National Health and Medical Research Council Principal Research fellowship. Daisy M X Abreu received institutional support from the Brazilian Ministry of Health (Proc number 25000192049/2014-14). Jennifer H MacLachlan receives funding support from the Australian Government Department of Health and Royal Melbourne Hospital Research Funding Program. Miriam Levi acknowledges institutional support received from CeRIMP, Regional Centre for Occupational Diseases and Injuries, Tuscany Region, Florence, Italy. Tea Lallukka reports funding from The Academy of Finland (grant 287488). No individuals acknowledged received additional compensation for their efforts. Funding Information: Carl Abelardo T Antonio reports grants, personal fees and non-financial support from Johnson \& Johnson (Philippines). Donald S Shepard acknowledges grant support from Sanofi Pasteur. Dariush Mozaffarian reports ad-hoc honoraria or consulting from Boston Heart Diagnostics, Haas Avocado Board, AstraZeneca, GOED, DSM, and Life Sciences Research Organization; and chapter royalties from UpToDate. Ettore Beghi reports grants from UCB-Pharma, during the conduct of the study; personal fees from Viropharma; grants from GSK, UCB-Pharma, Italian Drug Agency (AIFA), Italian Ministry of Health, EISAI, American ALS Association, and Borgonovo Foundation; and personal fees from Viropharma and GSK. Katherine B Gibney reports grants from CSL. Dan J Stein reports personal fees from Lundbeck, Novartis, AMBRF, Biocodex, Sevier, SUN, and CIPLA; and grants from MRC and NRGF. Peter A Meaney serves as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, a 501c3 entity; is on the steering committee of OMERACT, an international organisation that develops measures for clinical trials and receives arms-length funding from 36 pharmaceutical companies; consults for Savient, Takeda, Regeneron, Iroko, Merz, Bioiberica, Crealta, Allergan, WebMD, and UBM; and is supported by grants from Takeda and Savient. Mark G Shrime has received financial support from the GE Foundation Safe Surgery 2020 project and the Kletjian Foundation, and speaking fees from Ethicon (2014). Walter Mendoza reports that no additional funds were provided for his participation in this paper, but as an official of UNFPA Country Office in Peru, he stresses that his institution does not necessarily endorse the study. Aletta E Schutte is funded by the Medical Research Council of South Africa, and the South African Research Chair Initiative by the National Research Foundation. Charles D A Wolfe acknowledges that the research was funded and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. All other authors declare no competing interests. Publisher Copyright: {\textcopyright} 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license",

year = "2016",

month = oct,

day = "8",

doi = "10.1016/S0140-6736(16)31012-1",

language = "English",

volume = "388",

pages = "1459--1544",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10053",

}

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. / GBD 2015 Mortality and Causes of Death Collaborators.
In: The Lancet, Vol. 388, No. 10053, 08.10.2016, p. 1459-1544.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015

T2 - a systematic analysis for the Global Burden of Disease Study 2015

AU - GBD 2015 Mortality and Causes of Death Collaborators

AU - Wang, H.

AU - Naghavi, M.

AU - Allen, C.

AU - Barber, R. M.

AU - Carter, A.

AU - Casey, D. C.

AU - Charlson, F. J.

AU - Chen, A. Z.

AU - Coates, M. M.

AU - Coggeshall, M.

AU - Dandona, L.

AU - Dicker, D. J.

AU - Erskine, H. E.

AU - Ferrari, A. J.

AU - Fitzmaurice, C.

AU - Foreman, K.

AU - Forouzanfar, M. H.

AU - Johnson, C. O.

AU - Lim, S. S.

AU - Thomas, B. A.

AU - Bell, B.

AU - Brown, A.

AU - Brown, J.

AU - Cooper, C.

AU - Liu, S.

AU - Wang, L.

AU - Yu, S.

AU - James, P.

AU - Alam, K.

AU - Taylor, H. R.

AU - Agarwal, A.

AU - Kemp, A. H.

AU - Leigh, J.

AU - Basu, A.

AU - Lucas, R. M.

AU - Chen, W.

AU - Rahman, M.

AU - Singh, A.

AU - Khan, A. R.

AU - Huang, C.

AU - Huang, H.

AU - Zhang, H.

AU - Levi, M.

AU - Li, Y.

AU - Liu, Y.

AU - Phillips, M. R.

AU - Rahman, M.

AU - Saha, S.

AU - Shaddick, G.

AU - White, R. A.

N1 - Funding Information: We thank the countless individuals who have contributed to the Global Burden of Disease Study 2015 in various capacities. The data reported here have been supplied by the United States Renal Data System (USRDS). Data for this research was provided by MEASURE Evaluation, funded by the United States Agency for International Development (USAID). Collection of these data was made possible by USAID under the terms of cooperative agreement GPO-A-00-08-000_D3-00. Views expressed do not necessarily reflect those of USAID, the US Government, or MEASURE Evaluation. Parts of this material are based on data and information provided by the Canadian institute for Health Information. However, the analyses, conclusions, opinions and statements expressed herein are those of the author and not those of the Canadian Institute for Health information. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with licence number SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law–2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. The following individuals acknowledge various forms of institutional support. Simon I Hay is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), and grants from the Bill & Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023 and OPP1132415). Panniyammakal Jeemon is supported by a Clinical and Public Health Intermediate Fellowship from the Wellcome Trust-DBT India Alliance (2015–20). Luciano A Sposato is partly supported by the Edward and Alma Saraydar Neurosciences Fund, London Health Sciences Foundation, London, ON, Canada. George A Mensah notes that the views expressed in this Article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the United States Department of Health and Human Services. Boris Bikbov acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group supported by the International Society of Nephrology (ISN). Ana Maria Nogales Vasconcelos acknowledges that her team in Brazil received funding from Ministry of Health (process number 25000192049/2014-14). Rodrigo Sarmiento-Suarez receives institutional support from Universidad de Ciencias Aplicadas y Ambientales, UDCA, Bogotá, Colombia. Ulrich O Mueller and Andrea Werdecker gratefully acknowledge funding by the German National Cohort BMBF (grant number OIER 1301/22). Peter James was supported by the National Cancer Institute of the National Institutes of Health (Award K99CA201542). Brett M Kissela would like to acknowledge NIH/NINDS R-01 30678. Louisa Degenhardt is supported by an Australian National Health and Medical Research Council Principal Research fellowship. Daisy M X Abreu received institutional support from the Brazilian Ministry of Health (Proc number 25000192049/2014-14). Jennifer H MacLachlan receives funding support from the Australian Government Department of Health and Royal Melbourne Hospital Research Funding Program. Miriam Levi acknowledges institutional support received from CeRIMP, Regional Centre for Occupational Diseases and Injuries, Tuscany Region, Florence, Italy. Tea Lallukka reports funding from The Academy of Finland (grant 287488). No individuals acknowledged received additional compensation for their efforts. Funding Information: Carl Abelardo T Antonio reports grants, personal fees and non-financial support from Johnson & Johnson (Philippines). Donald S Shepard acknowledges grant support from Sanofi Pasteur. Dariush Mozaffarian reports ad-hoc honoraria or consulting from Boston Heart Diagnostics, Haas Avocado Board, AstraZeneca, GOED, DSM, and Life Sciences Research Organization; and chapter royalties from UpToDate. Ettore Beghi reports grants from UCB-Pharma, during the conduct of the study; personal fees from Viropharma; grants from GSK, UCB-Pharma, Italian Drug Agency (AIFA), Italian Ministry of Health, EISAI, American ALS Association, and Borgonovo Foundation; and personal fees from Viropharma and GSK. Katherine B Gibney reports grants from CSL. Dan J Stein reports personal fees from Lundbeck, Novartis, AMBRF, Biocodex, Sevier, SUN, and CIPLA; and grants from MRC and NRGF. Peter A Meaney serves as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, a 501c3 entity; is on the steering committee of OMERACT, an international organisation that develops measures for clinical trials and receives arms-length funding from 36 pharmaceutical companies; consults for Savient, Takeda, Regeneron, Iroko, Merz, Bioiberica, Crealta, Allergan, WebMD, and UBM; and is supported by grants from Takeda and Savient. Mark G Shrime has received financial support from the GE Foundation Safe Surgery 2020 project and the Kletjian Foundation, and speaking fees from Ethicon (2014). Walter Mendoza reports that no additional funds were provided for his participation in this paper, but as an official of UNFPA Country Office in Peru, he stresses that his institution does not necessarily endorse the study. Aletta E Schutte is funded by the Medical Research Council of South Africa, and the South African Research Chair Initiative by the National Research Foundation. Charles D A Wolfe acknowledges that the research was funded and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. All other authors declare no competing interests. Publisher Copyright: © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license

PY - 2016/10/8

Y1 - 2016/10/8

UR - https://www.scopus.com/pages/publications/84994158650

U2 - 10.1016/S0140-6736(16)31012-1

DO - 10.1016/S0140-6736(16)31012-1

M3 - Article

C2 - 27733281

AN - SCOPUS:84994158650

SN - 0140-6736

VL - 388

SP - 1459

EP - 1544

JO - The Lancet

JF - The Lancet

IS - 10053

ER -

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

UN SDGs

Access to Document

Other files and links

Cite this